Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale (NASDAQ:PTGX)

It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges ...